Bronchiectasis

Overview

Only N-Acetyl Cysteine (NAC) is indexed for bronchiectasis, with one low-rated study (WA 32) for effect size, evidence, and trust.

In adults with bronchiectasis, oral NAC 600 mg twice daily for one year lowered flare-up risk by 59% compared with as-needed treatment alone. For every eight people treated with NAC regularly, roughly one additional person remained flare-up free over the year versus those not taking NAC on schedule.

This finding comes from a single trial and needs replication. See the evidence review below for details.

Effect graph

Relevant supplements

Relevant supplements sorted by DEX Score.

Studies

Find individual evidence reviews for supplements sorted by DEX Score.

Evidence visualised

Same ratings as above, aggregated so you can see coverage and imbalance.